MA26758A1 - Composition nouvelle, a liberation modifiee, pour le traitement du diabete. - Google Patents

Composition nouvelle, a liberation modifiee, pour le traitement du diabete.

Info

Publication number
MA26758A1
MA26758A1 MA26192A MA26192A MA26758A1 MA 26758 A1 MA26758 A1 MA 26758A1 MA 26192 A MA26192 A MA 26192A MA 26192 A MA26192 A MA 26192A MA 26758 A1 MA26758 A1 MA 26758A1
Authority
MA
Morocco
Prior art keywords
diabetes
treatment
new
release composition
modified release
Prior art date
Application number
MA26192A
Other languages
English (en)
Inventor
Karen Lewis
Nicola Jayne Lilliott
Donald Colin Mackenzie
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of MA26758A1 publication Critical patent/MA26758A1/fr

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"Composition nouvelle, à libération modifiée, pour le traitement du diabète" L'invention concerne une composition pharmaceutique à libération modifiée. Cette composition comprend un sensibilisant à l'insuline, un autre agent antidiabétique et un support pharmaceutiquement acceptable. Application : utilisation de cette composition pour le traitement du diabète.
MA26192A 1998-11-12 2001-05-11 Composition nouvelle, a liberation modifiee, pour le traitement du diabete. MA26758A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9824866.9A GB9824866D0 (en) 1998-11-12 1998-11-12 Novel composition and use

Publications (1)

Publication Number Publication Date
MA26758A1 true MA26758A1 (fr) 2004-12-20

Family

ID=10842370

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26192A MA26758A1 (fr) 1998-11-12 2001-05-11 Composition nouvelle, a liberation modifiee, pour le traitement du diabete.

Country Status (5)

Country Link
CN (1) CN1762494A (fr)
CO (1) CO5150180A1 (fr)
GB (1) GB9824866D0 (fr)
MA (1) MA26758A1 (fr)
ZA (1) ZA200103843B (fr)

Also Published As

Publication number Publication date
CO5150180A1 (es) 2002-04-29
GB9824866D0 (en) 1999-01-06
ZA200103843B (en) 2002-05-14
CN1762494A (zh) 2006-04-26

Similar Documents

Publication Publication Date Title
TNSN98211A1 (fr) Association d'un inhibiteur d'aldose-reductase et d'un inhibiteur de glycogene-phosphorylase, et composition pharmaceutique la contenant
BR9810984A (pt) Composto de triazol, uso do mesmo, e, composição farmacêutica
TR200001218T2 (tr) İkameli karboksamidotiazoller, bunların üretimi ve bunları içeren farmasötik bileşimler.
BR0007500A (pt) Composto triazol, fármaco, e, uso do composto
BG105568A (en) Pharmaceutical compositions for modified release of an insulin sensitiser and another antidiabetic agent
TNSN99053A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
MA26728A1 (fr) COMPOSITION PHARMACEUTIQUE COMPRENANT UN INHIBITEUR DE CYP2D6 ET UN MÉDICAMENT à MÉTABOLISME CATALYSÉ PAR CYP2D6
DZ2520A1 (fr) Composition pharmaceutique pour une méthode de traitement du diabète sucré.
TNSN96104A1 (fr) Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant
PT958296E (pt) Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
MX9708621A (es) AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.
TNSN96072A1 (fr) N-(indole -2-carbonyl)-glycinamides substitues, procede pour leur preparation et compositions les contenant
BR0114410A (pt) Associação de um antagonista de receptor cb1 e de sibutramina, as composições farmacêuticas que os contêm e a respectiva utilização para o tratamento da obesidade
NO993646D0 (no) Tiazol benzensulfonamider som <beta>3-agonister for behandling av diabetes og fedme
ATE228360T1 (de) Stabilisierte schilddrüsenhormonhaltige arzneimittel
TNSN98182A1 (fr) Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
PT741716E (pt) Analogos de delta 12,13-iso-taxol sua utilizacao anti-neoplasica e composicoes farmaceuticas que os contem
TR200101961T2 (tr) 1,2-halkalı kinolin türevleri
TNSN99203A1 (fr) Compositions pharmaceutiques pour le traitement de la migraine, et procede pour leur preparation
BR9609653A (pt) Compostos e composições farmacêuticas contendo os mesmos
TNSN99001A1 (fr) Indoles 2,3-substitues servant d'agents anti-inflammatoires et analgesiques
DZ2539A1 (fr) Compositions pharmaceutiques pour le traitement dela résistance à l'insuline.
BR9909138A (pt) Combinação para o tratamento de dependência de álcool e drogas contendo um antagonista de opióide e um modulador de complexo receptor de nmda
ES2124905T3 (es) Esteroides antiglucocorticoides destinados al tratamiento de trastornos de ansiedad.
BR0011928A (pt) Composto, composição farmacêutica, uso de, um composto e métodos para o tratamento de complicações diabéticas, para o tratamento ou a prevenção do desenvolvimento de condições de doença associadas com velocidade de condução neuronial prejudicada e de neuropatia diabética